Patent foramen ovale is not associated with an increased risk of stroke recurrence

Eur J Neurol. 2010 Nov;17(11):1339-45. doi: 10.1111/j.1468-1331.2010.03015.x.

Abstract

Background and purpose: Despite numerous studies suggesting a relationship between paradoxical embolism from a patent foramen ovale (PFO) and stroke, the role of PFO as a risk factor for cerebral ischaemia remains controversial. We therefore sought to determine the association between a RLS detected by contrast-enhanced transcranial Doppler ultrasonography (c-TCD) and recurrent stroke in an unselected population sample.

Methods: We analyzed the records of 763 patients with diagnosis of cerebral ischaemia at our institution. All patients had undergone TCD-based detection of RLS. Embolic signals have been measured both under resting conditions and after performing a Valsalva maneuver. For follow-up, all patients were contacted by mail, which included a standardized questionnaire. Endpoints of follow-up were defined as recurrence of cerebral ischaemia, occurrence of myocardial infarction or death from any cause.

Results: Follow-up data were available in 639 patients (83.7%). At baseline, a RLS was detected in 140 (28%) men and in 114 (42%) women. Ten shunt-carriers (1.6%) and 32 patients (5.0%) without RLS had suffered a recurrent stroke. After adjustment for age, sex, and atrial fibrillation, the hazard ratio of RLS for stroke recurrence was 0.86 (95% CI 0.41-1.79). The condition of RLS at rest adjusted for age, sex, stroke subtype, and cardiovascular risk factors was not found to increase the risk of stroke substantially (HR 1.16 [95% CI 0.41-3.29])

Conclusion: Our data suggest that the risk of recurrent stroke in subjects with PFO is not significantly increased in comparison with subject without it.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Cohort Studies
  • Electrocardiography
  • Female
  • Foramen Ovale, Patent / complications*
  • Heart Rate / physiology
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / etiology
  • Neurologic Examination
  • Platelet Aggregation Inhibitors / therapeutic use
  • Proportional Hazards Models
  • Recurrence
  • Restless Legs Syndrome / complications
  • Restless Legs Syndrome / etiology
  • Risk Factors
  • Stroke / complications
  • Stroke / diagnosis*
  • Stroke / etiology*
  • Stroke / mortality
  • Ultrasonography, Doppler, Transcranial / methods

Substances

  • Platelet Aggregation Inhibitors